Sofinnova Management X-A

Mar 26, 2024 | streetinsider.com | Sofinnova Management X |Sofinnova Management X-A |a Delaware limited

1. SPY2. STOK3. AAPL4. ADBE5. F6. MSFT7. TSLA8. MTDR9. GME10. VKTX Tweet Share E-mail0 sharesSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549SCHEDULE 13D(RULE 13d-101)INFORMATION TO BE INCLUDED IN STATEMENTS FILEDPURSUANT TO RULE 13d-1(a)AND AMENDMENTS THERETO FILED PURSUANT TO RULE13d-2(a)(Amendment No. 4)*Vera Therapeutics, Inc. (Name of Issuer)Class A Common Stock, $0.001 par value(Title of Class of Securities)92337R101(CUSIP Number)Nathalie AuberSofinnova Investments, Inc.

Feb 20, 2024 | streetinsider.com | Sofinnova Management X-A

1. MRVL2. AVGO3. COST4. IOT5. GPS6. MDB7. DOCU8. GWRE9. SPY10. BJ Tweet Share E-mail0 sharesSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549SCHEDULE 13D(RULE 13d-101)INFORMATION TO BE INCLUDED IN STATEMENTS FILEDPURSUANT TO RULE 13d-1(a)AND AMENDMENTS THERETO FILED PURSUANT TO RULE13d-2(a)(Amendment No. 1)*Inozyme Pharma, Inc. (Name of Issuer)Common Stock, $0.0001 par value(Title of Class of Securities)45790W108(CUSIP Number)Nathalie AuberSofinnova Investments, Inc.

Feb 6, 2023 | streetinsider.com | Sofinnova Management X |a Delaware limited |James Healy |Sofinnova Management X-A

Form SC 13D/A Karuna Therapeutics, Filed by: Sofinnova Venture Partners X, L.P.February 6, 2023 6:02 AM EST Tweet Share E-mailGet inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. SECURITIES AND EXCHANGE COMMISSIONINFORMATION TO BE INCLUDED IN STATEMENTS FILEDPURSUANT TO RULE 13d-1(a)AND AMENDMENTS THERETO FILED PURSUANT TO RULE13d-2(a)Karuna Therapeutics, Inc. Common Stock, $0.0001 par value(Title of Class of Securities) Sofinnova Investments, Inc.